These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12039119)
1. Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Nguyen C; Duhl AJ; Escallon CS; Blakemore KJ Obstet Gynecol; 2002 Apr; 99(4):599-602. PubMed ID: 12039119 [TBL] [Abstract][Full Text] [Related]
2. Congenital cardiac defects: a possible association of aminopterin syndrome and in utero methotrexate exposure? Piggott KD; Sorbello A; Riddle E; DeCampli W Pediatr Cardiol; 2011 Apr; 32(4):518-20. PubMed ID: 21327892 [TBL] [Abstract][Full Text] [Related]
3. Methotrexate embryopathy in a surviving intrauterine fetus after presumed diagnosis of ectopic pregnancy: case report. Addar MH J Obstet Gynaecol Can; 2004 Nov; 26(11):1001-3. PubMed ID: 15560863 [TBL] [Abstract][Full Text] [Related]
4. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. Stephens JD; Golbus MS; Miller TR; Wilber RR; Epstein CJ Am J Obstet Gynecol; 1980 Jul; 137(6):747-9. PubMed ID: 7395946 [No Abstract] [Full Text] [Related]
5. When a fetus survives methotrexate exposure. Donoway T; Mandeville J; Gauer R J Fam Pract; 2012 Mar; 61(3):E1-4. PubMed ID: 22393560 [TBL] [Abstract][Full Text] [Related]
6. Anomalies associated with failed methotrexate and misoprostol termination. Yedlinsky NT; Morgan FC; Whitecar PW Obstet Gynecol; 2005 May; 105(5 Pt 2):1203-5. PubMed ID: 15863582 [TBL] [Abstract][Full Text] [Related]
8. Importance of timing of gestational exposure to methotrexate for its teratogenic effects when used in setting of misdiagnosis of ectopic pregnancy. Poggi SH; Ghidini A Fertil Steril; 2011 Sep; 96(3):669-71. PubMed ID: 21733506 [TBL] [Abstract][Full Text] [Related]
9. Teratogen update: methotrexate. Hyoun SC; Običan SG; Scialli AR Birth Defects Res A Clin Mol Teratol; 2012 Apr; 94(4):187-207. PubMed ID: 22434686 [TBL] [Abstract][Full Text] [Related]
10. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy. Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926 [TBL] [Abstract][Full Text] [Related]
11. New anomalies due to methotrexate and misoprostol exposure in early pregnancy. MacDonald K; Norman WV; Popescu O Int J Gynaecol Obstet; 2013 Sep; 122(3):267-8. PubMed ID: 23790744 [No Abstract] [Full Text] [Related]
12. Otocephaly: prenatal diagnosis of a new case and etiopathogenetic considerations. Ibba RM; Zoppi MA; Floris M; Putzolu M; Monni G; Todde PF; Sardu G Am J Med Genet; 2000 Feb; 90(5):427-9. PubMed ID: 10706365 [No Abstract] [Full Text] [Related]
13. Adult and two children with fetal methotrexate syndrome. Bawle EV; Conard JV; Weiss L Teratology; 1998 Feb; 57(2):51-5. PubMed ID: 9562676 [TBL] [Abstract][Full Text] [Related]
14. Severe limb defects and craniofacial anomalies in a fetus conceived during acitretin therapy. de Die-Smulders CE; Sturkenboom MC; Veraart J; van Katwijk C; Sastrowijoto P; van der Linden E Teratology; 1995 Oct; 52(4):215-9. PubMed ID: 8838291 [TBL] [Abstract][Full Text] [Related]
15. In utero first trimester exposure to low-dose methotrexate with increased fetal nuchal translucency and associated malformations. Krähenmann F; ØStensen M; Stallmach T; Huch A; Chaoui R Prenat Diagn; 2002 Jun; 22(6):489-90. PubMed ID: 12116309 [No Abstract] [Full Text] [Related]
16. [Prenatal diagnosis of skeletal dysplasia: case report of a fetus with multiple anomalies]. Novakov Mikić A; Stojić S; Konstantinidis G; Ristivojević A; Krnojelac D Med Pregl; 2000; 53(3-4):197-201. PubMed ID: 10965689 [TBL] [Abstract][Full Text] [Related]
17. Failed methotrexate termination of pregnancy: a case report. Goffman D; Cole DS; Bobby P; Garry DJ J Perinatol; 2006 Oct; 26(10):645-7. PubMed ID: 17006526 [TBL] [Abstract][Full Text] [Related]
18. Morphological features of a case of retinoic acid embryopathy. Van Maldergem L; Jauniaux E; Gillerot Y Prenat Diagn; 1992 Aug; 12(8):699-701. PubMed ID: 1438063 [TBL] [Abstract][Full Text] [Related]
19. [Severe bone malformations in fetal valproic acid disease]. Lorenzo Sanz G; Serna Saugar C; Quintana Castilla A; Lozano Giménez C; Aparicio Meix JM An Esp Pediatr; 1993 Jul; 39(1):19-21. PubMed ID: 8363144 [TBL] [Abstract][Full Text] [Related]
20. Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: Case report and literature review. Kennedy D; Webster WS; Hill M; Ritchie HE Reprod Toxicol; 2017 Apr; 69():146-149. PubMed ID: 28237611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]